These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6576846)

  • 1. Chronic liver disease in children with leukemia in long-term remission.
    Locasciulli A; Vergani GM; Uderzo C; Jean G; Cattaneo M; Vergani D; Portmann B; Masera G
    Cancer; 1983 Sep; 52(6):1080-7. PubMed ID: 6576846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP).
    Locasciulli A; Alberti A; Rossetti F; Santamaria M; Santoro N; Madon E; Miniero R; Lo Curto M; Tamaro P; Paolucci P
    Med Pediatr Oncol; 1985; 13(4):203-6. PubMed ID: 3859744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological evidence of hepatitis-B-virus infection with negative serology in children with acute leukaemia who develop chronic liver disease.
    Vergani D; Locasciulli A; Masera G; Alberti A; Moroni G; Tee DE; Portmann B; Mieli Vergani G; Eddleston AL
    Lancet; 1982 Feb; 1(8268):361-4. PubMed ID: 6120349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy.
    Locasciulli A; Santamaria M; Masera G; Schiavon E; Alberti A; Realdi G
    J Med Virol; 1985 Jan; 15(1):29-33. PubMed ID: 3855443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No adverse prognostic influence of hepatitis B virus infection in acute childhood lymphoblastic leukemia.
    Lampert F; Willems WR; Bertram U; Berthold F
    Blut; 1987 Aug; 55(2):115-20. PubMed ID: 3475137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of non-A, non-B hepatitis in children with acute leukemia and chronic liver disease.
    Locasciulli A; Alberti A; Barbieri R; Realdi G; Uderzo C; Portmann B; Masera G
    Am J Dis Child; 1983 Apr; 137(4):354-6. PubMed ID: 6402922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse prognostic influence of hepatitis B virus infection in acute lymphoblastic leukemia.
    Ratner L; Peylan-Ramu N; Wesley R; Poplack DG
    Cancer; 1986 Sep; 58(5):1096-100. PubMed ID: 3460683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis: clinical aspects.
    Redeker AG
    Am J Med Sci; 1975; 270(1):9-16. PubMed ID: 171956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to hepatitis B virus in children with papular acrodermatitis.
    Colombo M; Gerber MA; Vernace SJ; Gianotti F; Paronetto F
    Gastroenterology; 1977 Nov; 73(5):1103-6. PubMed ID: 332578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver disease complicating the management of acute leukemia during remission.
    Armitage JO; Burns CP; Kent TH
    Cancer; 1978 Feb; 41(2):737-42. PubMed ID: 630548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B in pediatrics. Considerations on vaccination in leukemia].
    Cimaglia A; Villani S; Buonagura G; Cimaglia ML; Labate L; D'Antonio G; Scognamiglio D; Scala G
    Pediatr Med Chir; 1986; 8(4):547-9. PubMed ID: 3575130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant hepatic failure during remission from leukemia: three cases associated with massive liver cell necrosis and hepatitis B virus.
    Watanabe A; Higashi T; Endo H; Nagashima H
    Acta Med Okayama; 1979 Aug; 33(4):245-57. PubMed ID: 158950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of asymptomatic hepatitis B surface antigen carriers.
    de Franchis R; Meucci G; Vecchi M; Tatarella M; Colombo M; Del Ninno E; Rumi MG; Donato MF; Ronchi G
    Ann Intern Med; 1993 Feb; 118(3):191-4. PubMed ID: 8417636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe liver disease is caused by HBV rather than HCV in children with hematological malignancies.
    El-Sayed MH; Mohamed MM; Karim A; Maina AM; Oliveri F; Brunetto MR; Bonino F
    Hematol J; 2003; 4(5):321-7. PubMed ID: 14502256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis in patients with acute nonlymphocytic leukemia.
    Wade JC; Gaffey M; Wiernik PH; Schimpff SC; Schiffer CA; Wesley M; Hoofnagle JH
    Am J Med; 1983 Sep; 75(3):413-22. PubMed ID: 6412546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
    Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.